PP
HIMS icon

PDT Partners’s Hims & Hers Health HIMS Stock Holding History

PDT Partners’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-205,234
Closed -$1.15M – 748
2022
Q3 		$1.15M Buy
+205,234
New +$1.24M 0.17% 183

Other funds holding HIMS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RM
Redpoint Management Woodside, California $201M AUM 39.14% 1-Year Est. Return
IVMX
Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return
IVMX
Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

PDT Partners's HIMS Position: Q4 2022 in Review

PDT Partners sold out of Hims & Hers Health (HIMS) in Q4 2022, closing a stake of 205,234 shares — an estimated $1.15M sold.

PDT Partners first reported a position in HIMS in Q3 2022 and held it in 1 quarter. The position peaked at $1.15M in Q3 2022. 156 funds tracked by Wall St. Rank hold HIMS as of Q4 2022.

  • PDT Partners reported no remaining Hims & Hers Health position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 205,234 Hims & Hers Health shares in Q4 2022, an estimated $1.15M.
  • PDT Partners first reported a position in Hims & Hers Health in Q3 2022 and held it in 1 quarter.
  • PDT Partners's Hims & Hers Health position peaked at $1.15M in Q3 2022.
  • 156 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.